Podium Presentations

1. Willis M, Neslusan C, Nilsson A, Asseburg C. Diabetic Kidney Disease (DKD) and Renal Protection in T2DM: An Underappreciated Driver of C-E in Economic Evaluation? Presented at 9th Mt Hood Diabetes Challenge Network Meeting, Dusseldorf, Germany, 6-7 October. 2018.

2. Willis M, Asseburg C, Nilsson A. Challenges and Opportunities Associated with Modeling Cardioprotection in Economic Evaluation: Some Initial Reflections – Presented at 9th Mt Hood Diabetes Challenge Network Meeting, Dusseldorf, Germany, 6-7 October. 2018.

3. Willis M, Neslusan C, Johansen P, Nilsson A, Asseburg C, Schroeder M. The Economic Consequences of Clinical Inertia in Treatment Intensification for Type 2 Diabetes Mellitus (T2DM) in the UK. Podium presentation at EASD 51st Annual Meeting. Stockholm, Sweden 2015.

4. Willis M, Neslusan C, He J. Implications of Key Biomarker Trends on Health Outcomes in Patients with Type 2 Diabetes Mellitus (T2DM) in the US Podium presentation at ADA 72nd Scientific Sessions. Philadelphia, Pennsylvania, USA 2012.

5. Willis M, Neslusan C, Asseburg C, He J. Initial HbA1c and HbA1c Lowering: Implications for Model-Based Economic Evaluations in Type 2 Diabetes Mellitus (T2DM). Podium presentation at ADA 71st Scientific Sessions. San Diego, CA, USA 2011.

6. Willis M, Asseburg C, He J, Neslusan C. Validation of Economic Simulation Models Using Clinical Trial Results: Experiences from Type 2 Diabetes Mellitus (T2DM). Podium presentation at iHEA World Congress. Toronto, Canada 2011.

7. Willis M, Asseburg C, Neslusan C, He J. The Economic Importance of Metabolic Memory in the Treatment of Type 2 Diabetes Mellitus (T2DM). Podium presentation at ADA 70th Scientific Sessions. Orlando, Florida, USA 2010.

8. Willis M, Asseburg C, He J, Neslusan C. The Cost-Effectiveness of “Getting-to Goal” in Patients with Newly Diagnosed Type 2 Diabetes Podium presentation at ADA 69th Scientific Sessions New Orleans, Louisiana, USA 2009.

9. Willis M, Asseburg C, Neslusan C, Persson U. The Cost-Effectiveness of the Early Insulin Use Treatment Pathway in the ADA/EASD Joint Consensus Algorithm for the Treatment of Type 2 Diabetes. Podium presentation at ADA 68th Scientific Sessions. San Francisco, CA, USA 2008.

10. Willis M, Neslusan C. Opportunities to Use Economic Modeling for Internal Pharma Decision-Making in T2DM. Podium presentation at iHEA 6th World Congress. Copenhagen, Denmark 2007.

Contact


For more information, please contact: diabetesmodelling@ihe.se